Insider Trading History of Lin Elizabeth Yeu

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lin Elizabeth Yeu since 2022. This trader's CIK number is 1842190. At the time of last reporting, Lin Elizabeth Yeu was the Chief Medical Officer of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS). Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..

Note that in the past Lin Elizabeth Yeu also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Staar Surgical Co (STAA) by Lin Elizabeth Yeu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 STAA 2,500 $100,000 0 $0 0 $0
2022 STAA 0 $0 0 $0 355 $0

Yearly summary of insider trading at Tarsus Pharmaceuticals, Inc. (TARS) by Lin Elizabeth Yeu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TARS 0 $0 1,006 $41,326 3,350 $0
2024 TARS 0 $0 0 $0 3,350 $0
2023 TARS 19,012 $319,400 0 $0 2,000 $0


Insider trading activities at 2 companies by Lin Elizabeth Yeu:

1. Staar Surgical Co (STAA)

2. Tarsus Pharmaceuticals, Inc. (TARS)

Table 1. Insider trading of Staar Surgical Co (STAA) by Lin Elizabeth Yeu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-21 STAA Buy 2,500 40.00 100,000
2022-06-16 STAA Option Ex 355 .00 0

Table 2. Insider trading of Tarsus Pharmaceuticals, Inc. (TARS) by Lin Elizabeth Yeu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-13 TARS Option Ex 3,350 .00 0
2025-06-16 TARS Sale 1,006 41.08 41,326
2024-06-24 TARS Option Ex 3,350 .00 0
2023-08-15 TARS Buy 9,506 16.80 159,700
2023-08-15 TARS Buy 9,506 16.80 159,700
2023-06-16 TARS Option Ex 2,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lin Elizabeth Yeu (Chief Medical Officer of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.